Xenon Pharmaceuticals
XENE
#2957
Rank
โ‚ฌ4.81 B
Marketcap
50,44ย โ‚ฌ
Share price
2.17%
Change (1 day)
71.91%
Change (1 year)

EPS for Xenon Pharmaceuticals (XENE)

EPS in 2025 (TTM): -3,77ย โ‚ฌ

According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -3,68ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,55ย โ‚ฌ a decrease over its 2023 EPS that were of -2,30ย โ‚ฌ.

EPS history for Xenon Pharmaceuticals from 2022 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,77ย โ‚ฌ47.75%
2024-2,55ย โ‚ฌ11.03%
2023-2,30ย โ‚ฌ33.33%
2022-1,72ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Coherus BioSciences
CHRS
1,12ย โ‚ฌ-130.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
1,88ย โ‚ฌ-150.92%๐Ÿ‡บ๐Ÿ‡ธ USA